Page last updated: 2024-10-29

iohexol and Behcet Syndrome

iohexol has been researched along with Behcet Syndrome in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Behcet Syndrome: Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Temizöz, O1
Genchellac, H1
Yekeler, E1
Demir, MK1
Unlü, E1
Ozdemir, H1

Other Studies

1 other study available for iohexol and Behcet Syndrome

ArticleYear
CT-angiographic demonstration of hepatic collateral pathways due to superior vena cava obstruction in Behçet disease.
    Diagnostic and interventional radiology (Ankara, Turkey), 2010, Volume: 16, Issue:4

    Topics: Behcet Syndrome; Collateral Circulation; Contrast Media; Diagnosis, Differential; Female; Humans; Im

2010